Clinical Research Directory
Browse clinical research sites, groups, and studies.
Urinary G3BP as a Novel Biomarker in Lupus Nephritis
Sponsor: Assiut University
Summary
Estimation of urinary Galectin-3 binding protein (u-Gal-3BP) in patients with systemic lupus erythematosus with and without lupus nephritis and in glomerulonephritis for other kidney diseases, Find the relation of urinary Galectin-3 binding protein (u-Gal-3BP) levels with lupus nephritis, and Correlate urinary Galectin-3 binding protein (u-Gal-3BP) levels with SLE disease activity
Official title: Urinary galectin_3 Binding Protein as a Novel Biomarker in Lupus Nephritis and Indicator for Disease Activity
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
70
Start Date
2024-09
Completion Date
2025-10
Last Updated
2024-07-26
Healthy Volunteers
No
Conditions
Interventions
Urinary galectin-3 binding protein
Investigate urinary galectin-3 binding protein (G3BP) as a biomarker for lupus nephritis and indicator for disease activity.